245 related articles for article (PubMed ID: 29561254)
1. Interleukin-35 stimulates hepatitis B virus transcription and replication by targeting transcription factor HNF4α.
Tao NN; Gong R; Chen X; He L; Ren F; Yu HB; Chen J; Ren JH
J Gen Virol; 2018 May; 99(5):645-654. PubMed ID: 29561254
[TBL] [Abstract][Full Text] [Related]
2. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
3. Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.
Zhao Z; Hong W; Zeng Z; Wu Y; Hu K; Tian X; Li W; Cao Z
J Biol Chem; 2012 Aug; 287(36):30181-90. PubMed ID: 22791717
[TBL] [Abstract][Full Text] [Related]
4. Luteolin Inhibits Hepatitis B Virus Replication through Extracellular Signal-Regulated Kinase-Mediated Down-Regulation of Hepatocyte Nuclear Factor 4α Expression.
Bai L; Nong Y; Shi Y; Liu M; Yan L; Shang J; Huang F; Lin Y; Tang H
Mol Pharm; 2016 Feb; 13(2):568-77. PubMed ID: 26656210
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis B Virus replication by hepatocyte nuclear factor 4-alpha specific short hairpin RNA.
He F; Chen EQ; Liu L; Zhou TY; Liu C; Cheng X; Liu FJ; Tang H
Liver Int; 2012 May; 32(5):742-51. PubMed ID: 22340507
[TBL] [Abstract][Full Text] [Related]
6. Biological characteristics of the A1762T/G1764A mutant strain of hepatitis B virus in vivo.
Leng XH; Chen EQ; Du LY; Bai L; Gong DY; Cheng X; Huang FJ; Tang H
Mol Med Rep; 2015 Oct; 12(4):5141-8. PubMed ID: 26165271
[TBL] [Abstract][Full Text] [Related]
7. Transcription and replication of a natural hepatitis B virus nucleocapsid promoter variant is regulated in vivo by peroxisome proliferators.
Raney AK; Kline EF; Tang H; McLachlan A
Virology; 2001 Oct; 289(2):239-51. PubMed ID: 11689047
[TBL] [Abstract][Full Text] [Related]
8. Rimonabant suppresses RNA transcription of hepatitis B virus by inhibiting hepatocyte nuclear factor 4α.
Sato A; Ono C; Tamura T; Mori H; Izumi T; Torii S; Fauzyah Y; Yamamoto T; Morioka Y; Okuzaki D; Fukuhara T; Matsuura Y
Microbiol Immunol; 2020 May; 64(5):345-355. PubMed ID: 31981244
[TBL] [Abstract][Full Text] [Related]
9. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.
Hösel M; Quasdorff M; Wiegmann K; Webb D; Zedler U; Broxtermann M; Tedjokusumo R; Esser K; Arzberger S; Kirschning CJ; Langenkamp A; Falk C; Büning H; Rose-John S; Protzer U
Hepatology; 2009 Dec; 50(6):1773-82. PubMed ID: 19937696
[TBL] [Abstract][Full Text] [Related]
10. SOX9 represses hepatitis B virus replication through binding to HBV EnhII/Cp and inhibiting the promoter activity.
Yang H; Zhou Y; Mo J; Xiang Q; Qin M; Liu W; Shang J; Yang Q; Xu W; Yang G; Tan Q; Wu K; Liu Y; Wu J
Antiviral Res; 2020 May; 177():104761. PubMed ID: 32147495
[TBL] [Abstract][Full Text] [Related]
11. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
12. FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4α.
Li L; Li Y; Xiong Z; Shu W; Yang Y; Guo Z; Gao B
Antiviral Res; 2019 Oct; 170():104568. PubMed ID: 31351930
[TBL] [Abstract][Full Text] [Related]
13. [Effect of the cytoplasmic DNA sensor DAI on replication of hepatitis B virus].
Wang Q; Li S; Huang H; Liu S; Yang Y; Yang D
Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):934-8. PubMed ID: 26739467
[TBL] [Abstract][Full Text] [Related]
14. Tripartite motif-containing protein 21 is involved in IFN-γ-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors.
Won J; Kang HS; Kim NY; Dezhbord M; Marakkalage KG; Lee E-H; Lee D; Park S; Kim D-S; Kim K-H
J Virol; 2024 Jun; 98(6):e0046824. PubMed ID: 38780244
[TBL] [Abstract][Full Text] [Related]
15. Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling.
Lin Y; Wu C; Wang X; Liu S; Zhao K; Kemper T; Yu H; Li M; Zhang J; Chen M; Zhu Y; Chen X; Lu M
Autophagy; 2020 Mar; 16(3):548-561. PubMed ID: 31204557
[TBL] [Abstract][Full Text] [Related]
16. ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication.
Wang ZY; Li YQ; Guo ZW; Zhou XH; Lu MD; Xue TC; Gao B
Acta Pharmacol Sin; 2020 Feb; 41(2):278-285. PubMed ID: 31554961
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression.
Hong MH; Chou YC; Wu YC; Tsai KN; Hu CP; Jeng KS; Chen ML; Chang C
PLoS One; 2012; 7(1):e30360. PubMed ID: 22276183
[TBL] [Abstract][Full Text] [Related]
18. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
[TBL] [Abstract][Full Text] [Related]
19. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
[TBL] [Abstract][Full Text] [Related]
20. Saikosaponin C exerts anti-HBV effects by attenuating HNF1α and HNF4α expression to suppress HBV pgRNA synthesis.
Pan Y; Ke Z; Ye H; Sun L; Ding X; Shen Y; Zhang R; Yuan J
Inflamm Res; 2019 Dec; 68(12):1025-1034. PubMed ID: 31531682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
